Nexel Total Elbow
DeviceNexel Total Elbow used in primary or revision total elbow arthroplasty
Other names: Nexel Elbow, Nexel
NCT Number: NCT02469662
The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Sydney Shoulder & Elbow, NSW, Sydney, New South Wales, Australia
The objectives of the study are to confirm safety and performance of the Zimmer® Nexel™ Total Elbow when used in primary or revision total elbow replacement by analysis of standard scoring systems, radiographs, and adverse event records.
The safety of the device will be monitored using the frequency and incidence of reporting adverse events.
The performance of the device will be evaluated by assessing the pain and functional performance, survival of the device, patient health status, and radiographic success of the implant.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Additional Retrospective Arm Inclusion Criteria
Exclusion criteria
Nexel Total Elbow used in primary or revision total elbow arthroplasty
Other names: Nexel Elbow, Nexel
Time frame: 10 years
Based on removal or intended removal of the device and determined using the Kaplan-Meier method
Contact information is provided by the study sponsor or research team.
Richard Marek
CONTACT
Ryan Boylan
CONTACT
Zimmer Biomet
Industry
Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06546345
Arthritis, Arthritis, Rheumatoid
Besançon, France
View Trial DetailsNCT06917235
Ankylosis, Arthritis
Drammen, Norway
View Trial DetailsNCT05318521
Arthritis, Degenerative Arthritis
Cerritos, California, United States
View Trial DetailsNCT02038140
Arthritis, Arthritis, Rheumatoid
Sacramento, California, United States
View Trial Details